Veracity Capital’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $888K | Sell |
1,994
-108
| -5% | -$48.1K | 0.3% | 68 |
|
|
2025
Q1 | $1.02M | Buy |
2,102
+83
| +4% | +$40.2K | 0.39% | 53 |
|
|
2024
Q4 | $813K | Buy |
2,019
+401
| +25% | +$161K | 0.29% | 75 |
|
|
2024
Q3 | $752K | Buy |
1,618
+232
| +17% | +$108K | 0.29% | 72 |
|
|
2024
Q2 | $650K | Sell |
1,386
-30
| -2% | -$14.1K | 0.27% | 73 |
|
|
2024
Q1 | $592K | Buy |
1,416
+177
| +14% | +$74K | 0.23% | 97 |
|
|
2023
Q4 | $504K | Buy |
1,239
+54
| +5% | +$22K | 0.2% | 105 |
|
|
2023
Q3 | $412K | Buy |
1,185
+49
| +4% | +$17K | 0.19% | 111 |
|
|
2023
Q2 | $400K | Buy |
1,136
+25
| +2% | +$8.8K | 0.17% | 126 |
|
|
2023
Q1 | $350K | Buy |
1,111
+18
| +2% | +$5.67K | 0.16% | 140 |
|
|
2022
Q4 | $316K | Buy |
1,093
+76
| +7% | +$21.9K | 0.15% | 141 |
|
|
2022
Q3 | $294K | Buy |
+1,017
| New | +$294K | 0.16% | 138 |
|
|
2020
Q4 | – | Sell |
-2,180
| Closed | -$594K | – | 247 |
|
|
2020
Q3 | $594K | Buy |
2,180
+400
| +22% | +$109K | 0.16% | 145 |
|
|
2020
Q2 | $516K | Buy |
+1,780
| New | +$516K | 0.14% | 146 |
|